Objectives: To develop an ultrasound enthesis score, and to assess its validity in the spondyloarthropathies (SpA) diagnostic classification. Methods: Twenty five SpA patients and 29 healthy controls participated in a blinded, gender-matched, cross-sectional study involving ultrasound assessment. The following enthesis were explored bilaterally: proximal plantar fascia, distal Achilles tendon, distal and proximal patellar ligament, distal quadriceps, and brachial triceps tendons. The ultrasound score evaluated enthesis thickness, structure, calcifications, erosions, bursae, and power Doppler signal. The value of each elemental lesion was calculated using a three model analysis. The validity was analyzed by ROC curves. Inter-reader and interexplorer intraclass correlation coefficients (ICC) were calculated. Results The logistic regression model overestimated the score of three elemental lesions: calcification (0-3), Doppler (0 or 3), and erosion (0 or 3), while scoring tendon structure, tendon thickness and bursa as 0 or 1. ROC curves established an ultrasound score of 17 as the best cut-off point to differentiate between cases and controls. This cut-off point was exceeded by 5 of 29 controls (17 %), and by 21 of 25 SpA patients (84 %). In contrast, 4 of 25 (16 %) SpA cases and 24 of 29 healthy controls (83 %) did not exceed the cut-off point. The sensitivity, specificity, positive likelihood ratio (LR+), and the negative likelihood ratio (LR-) were 83.33%, 82.76%, 4.83%, and 0.201% respectively. The inter-reader and inter-explorer ICCs were 0.60 and 0.86 respectively.
The diagnosis of spondyloarthropathy (SpA) is often made several years after the disease begins. The Rome, New York, and the modified New York criteria for the classification of ankylosing spondylitis (AS) have high specificities, but their sensitivities are low (1,2). The absence of both radiographic sacroiliitis and impaired spinal mobility at early stages of the disease contributes to the long delay (5-10 years) in the diagnosis of AS in many patients (3) . On the other hand, inflammatory involvement of the enthesis, a characteristic feature of spondyloarthropathies, is regarded as the primary lesion in this disease (4, 5) . A tenderness enthesitis index at 66 entheseal insertions in SpA has been developed. This index correlates with pain and stiffness scores, yet is time consuming and has poor inter-observer reliability (6). At the present time, only clinical evidence of heel enthesitis is included in the European Spondylarthropathy Study Group (ESSG) Preliminary Classification Criteria for the diagnosis of SpA (7) . However, ultrasound (US) detection of enthesitis is more sensitive and specific than clinical examination, and furthermore, it is reproducible (8, 9, 10) . The aim of this study is to explore the validity of enthesis ultrasonography for the classification diagnosis of SpA.
cases of AS (modified New York criteria), 2 cases of undifferentiated SpA, 1 case of juvenile SpA, 2 cases of psoriatic arthritis, and 1 cases of reactive arthritis. The mean disease evolution time was 15 years (range 4-34 years). Exclusion criteria included: a history of knee, ankle, or elbow surgery, peripheral neuropathy, or corticosteroid injection within the previous six weeks at any of the sites to be examined. Twenty nine healthy controls (friend of hospital workers or patients), without any known inflammatory or mechanical musculoskeletal disease were invited to participate. Due to ethical reasons, no analytical or radiological studies, except a brief anamnesis were performed on the control group. The study was approved by the hospital ethics committee, and both patients and controls gave their informed consent.
Ultrasound evaluation
Ultrasonography (US) was performed by an experienced rheumatologist, using a GE Logiq 5 Pro ultrasound system (General Electric Healthcare), with a 7-12 MHz linear array transducer. The sonographer was blinded to patients and controls, and subjects were asked not to communicate with the US examiner. The US study bilaterally explored entheses at six sites: proximal plantar fascia, distal Achilles tendon, distal and proximal patellar tendon insertion, distal quadriceps tendon, and distal brachial triceps tendon. Each tendon was scanned in both the longitudinal and transverse planes. Knee enthesis examination was performed with the patient in the supine position and the knee flexed at 70 degrees. The Achilles tendon and the plantar aponeurosis were examined with the patient lying prone and the feet hanging over the edge of the examination table at 90 degrees of flexion. The triceps insertion was examined with the arm flexed at 90º. The ultrasound exploration evaluated the following elemental lesions of enthesis at each site: calcifications, bursas, erosions, power Doppler signal in bursa or enthesis full tendon (cortical bone profile, intratendon, and paratendon on the enthesis insertion), and thickness and structure (Figure 1-2) . a) Calcifications were examined at the area of the enthesis insertion, and scored as 0 if absent, or a 1 if a small calcification or ossification with an irregularity of enthesis cortical bone profile was seen. Calcifications were given a score of 2 if there was clear presence of enthesophytes (hyperechoic spurs forming at a tendon insertion into bone, growing in the direction of the natural pull of the tendon involved), or if medium sized calcifications or ossification were observed. Lastly, they were classified as a 3 if large calcifications or ossifications were present. To simplify things, ossifications and enthesophytes at the enthesis were also included as calcifications. b) Bursitis was defined as a well circumscribed, localized anechoic or hypoechoic area at the site of an anatomical bursa, which was compressible by the transducer (11,12). c) Bony erosion was defined as a cortical breakage with a step down bone contour defect of in-longitudinal and transversal axes. d) Power Doppler settings were standardized with a pulse repetition frequency of 400
Hz, a gain of 20 dB, and a low wall filter. e) Fascia and tendon thickness were measured at the point of maximal thickness on the bony insertion. The following criteria were used for abnormal structure thickness: quadriceps tendon thickness >6.1 mm, proximal and distal patellar tendon >4 mm, Achilles tendon >5.29 mm, and plantar aponeurosis >4.4 mm (8) . The normal ultrasound features and thickness of the structures examined have been previously described (8) . To reduce subjectivity, the threshold of abnormal thickness was set 0.1 mm above the reported standard deviation of each site in the normal population (8) . We used >4.3 mm as the measure for abnormal structure thickness of triceps insertion; this value was based on our own controls (mean ± standard deviation of 29 controls: 3.66 mm ± 0.54), then 0.1 mm above the standard deviation was added. Structure was defined as pathological if loss of fibrillar pattern, hypoechoic aspect, or fusiform thickening of the enthesis was appreciated. For reliability, an inter-reader and inter-explorer analysis was carried out. The sonographic images for each subject were stored. Inter-reader agreement was measured for six rheumatologists at five hospitals in the area of Madrid. All were experts in musculoskeletal ultrasonography, although only two had previous experience with the enthesis US score [readers 1 (EDM) and 2 (TC) worked in the same department and were directly involved in the development of the index]. As a result of its geographical origin, the score was called the Madrid Sonographic Enthesis Index (MASEI). An agreement on ultrasonographic definitions was reached prior to the inter-reader assessment. The first 17 patients and 19 controls were used in the inter-reader study. Each case and control in this reliability study, were masked in individual blocks and had a bilateral enthesis exploration as previously described. In total, 1,363 digital images were read by each of the experts. In addition, an inter-explorer study of 22 subjects (cases and controls) was conducted. For this purpose, each subject was independently blinded and consecutively scanned by two of the rheumatologists involved in the study (TC and EDM). For quantification of the enthesis lesions, the procedure described above was also used.
Statistical
To determine the value of every elemental lesion, a three model analysis was used: logistic regression, main components, and latent class model. Receiver Operating Characteristics (ROC) curves were used to calculate the predictive capacity of the score for every US reader and for the final score (Table 1) . ROC curves and model analysis were determined by the ESTATA program. For the reliability analysis, the two-way mixed effect model (absolute agreement) and single measure intraclass correlation coefficients (ICC) were used. They were determined by SPSS (version 9, SPSS, Inc Chicago IL). Values of p <0.05 were considered to be significant.
Results

Demographic data
The study sample included 29 healthy subjects (19 male,10 female) with a mean age of 46.13±13.43 years (range 22-64) and 25 SpA patients (16 male, 9 female) mean age 43.33±15.55 years (range 17-70). Both, age and gender ratio were comparable.
Value of enthesis elemental lesions
The number and score of elemental lesions were significantly greater than in controls (Figure 3) . Following the determination of the number and score of elemental lesions, the appropriate value of each lesion was investigated. Three different statistical models were used to estimate the accurate value of every elemental lesion. The chosen logistic regression model overestimated three elemental lesions and established that the best predictive value was reached when calcifications were scored on a semi-quantitative score of 0-3, Doppler and erosions were scored as 0 or 3 points, and scores for tendon structure, tendon thickness and bursa were either 0 or 1 (Table 2 ). Main components and latent class models showed similar results with minor differences and a lesser area under the curve. US abnormalities can be easily seen in healthy controls; Figure 3 shows how the extent of abnormalities rather than the presence of them discriminates between SpA and controls.
Validity of the sonography enthesitis index in SpA
To explore the concurrent criterion validity, ROC curves were determined from the values assigned to each elemental lesion by the logistic regression model. As result, a value of ≥ 18 was established as the best cut-off point to differentiate between cases and controls ( Table 1 ). The ROC area under the curve was 0.8886 (95% CI 0.7969-0.9804).This cut-off point was exceeded by 5 of 29 controls (17 %) and by 21 of 25 SpA patients (84 %), whereas 4 of 25 (16 %) SpA cases and 24 of 29 healthy controls (83 %) did not reach this score. The mean value of the MASEI score was (mean ± SD) 12.96 ± 7.84 in the control group and 25.44 ± 7.92 in the SpA patients (p < 0.0001). Healthy women had a lower ultrasound enthesis index (9.50 ± 4.14) than SpA women (25.25 ± 6.84); p < 0.05. Healthy males had also a lower ultrasound score when compared with SpA males, 14.79 ± 8.77 vs. 25.78 ± 10.02; however this difference was not statistically significance. No gender differences were found in the SpA group 
Discussion
To the best of our knowledge, this is the first study to investigate the validity of enthesis ultrasonography for the diagnosis classification in SpAs. These results are encouraging, and open new insights for the use of enthesis US in SpA. Previous studies in this field have provided important and preliminary data about the relevance of enthesis US in SpAs (8,9,13,14,15.16). As in other studies, these results demonstrated a high frequency of abnormal peripheral enthesis in patients compared to controls ( Figure. 3) (8,9) . In order to use a enthesis US score with diagnostic purposes, a strict methodological process that includes face validity, content validity, criterion validity, construct validity, discriminant validity, and feasibility must be followed. Following this approach, the current study included additional dimensions of validity which have not been previously assessed in enthesis ultrasound. The first objective was to develop a sum score (table 2) with a degree of sensitivity and specificity sufficient to differentiate SpA from controls. Balint et al., developed the GUESS (Glasgow Ultrasound Enthesitis Scoring System), a quantitative US score of lower limb enthesis, and showed that most of the enthesopathies that were demonstrated with US were not detected when clinical examination was performed (8) . The GUESS index has face and content validity because it measures what we theoretically are supposed to measure and it covers different aspects of the enthesis such as calcifications, thickness, erosions, and bursa in multiple enthesis. In order to ameliorate the face and content validity, our score added both structural aspects of the enthesis (hypoechoic, loss of fibrillar pattern, hypoechoic aspect, and fusiform thickening) and the power Doppler signal, as a useful tool to evaluate enthesis and bursa blood flow (9,16). Another aspect of face validity is the determination of which enthesis should be scanned. For this purpose, the most representative and frequently affected entheses reported in previous studies were chosen (8, 9, 16 ). In addition, an enthesis of the upper limb was desirable, based on the hypothesis that at this level there will be less influence of the possible mechanical problems than in the lower limb. The olecranon was explored because in previous experience it affected 60% of the SpA patients. The epicondyles were not examined as other studies did (9) , because that would have increased the number of enthesis to explore, and could potentially introduce mechanical issues. Furthermore, the mathematical calculations improved the accuracy and validity of the value of every elemental lesion in the final index as shown in the ROC curve results. This statistical approach has not been previously used for the calculation of the values assigned to build SpA US scores (8,9,16). The concurrent criterion validity (the degree that a measure or test reflects a gold standard applied to the same subject) was previously determined by D`Agostino et al. (9) . Their research clearly showed differences of US enthesis findings between SpA, rheumatoid arthritis and mechanical back pain patients (9) . The current study went one step further in exploring the usefulness of US as a diagnostic tool. This test showed a good sensitivity, specificity, LR+, and LR-. The validity of the score depends on the 12 entheses, because a lower number or unilateral exploration reduces the area under the curve of the score. It was the number of elemental lesions rather than the presence or absence of the lesions, which discriminated between SpA and controls. A possible bias might happen if patients could be recognized by the US rheumatologist as having the disease. However, due to the blindness characteristics of the study this situation could only be possible in very few occasions, therefore we think that bias was not relevant. The gender-matched sub-analysis of this study showed that control women had a statistically significant reduced number of lesions in enthesis than men. As a result of this observation, future studies including a control population might be gender-matched. On the other hand, the US score in SpA patients is as sensitive in women as in men, and the MASEI score can be used in both. This finding has relevant clinical implications in women, in whom the diagnosis of SpA with classical methods is difficult, due to both a less extensive decrease in spinal mobility and lower radiological damage. Power Doppler ultrasonography has demonstrated increased vascularity, which is related to inflammation that occurs in enthesitis (9,16), as well as sensitivity to change, discriminant validity an other aspect of validity of construct (18,19). These properties make power Doppler US a relevant component of a US score. In the present study, power Doppler had a good sensitivity and specificity in the global score. Furthermore, most patients in this cross-sectional study were not clinically active, but 60% had a Doppler signal in at least one enthesis. Occasionally, a power Doppler signal was also seen in controls, but to a lesser extent than in patients. This study used only a cortical power Doppler signal with good results (9) . This measure is probably more specific, but the sensitivity could be lower, which might decrease its strength when used for diagnostic applications. Differences among ultrasound machines might also account for these disparities. Another dimension to consider in the validation process is reproducibility. Previous reports have studied the intra-observer and inter-observer reliability of US in enthesis (8, 9, 16 ). This study investigated inter-reader and inter-explorer reliability. The interreader study had the distinctiveness of six readers from five different centers, and this most likely increased the strength of the score, because reliability is always higher among investigators working in the same center. The results showed that MASEI can be implemented by other investigators. Nonetheless, experience and training is crucial to improve the results. Table 3 shows that readers who were familiar with the development of the index (readers 1 and 2) had better sensitivity and a better percentage of correctly assigned cases and controls (ICC: 0.83). However, readers 3, 4, and 5 who had not been involved in the score development reached ICC agreements comparable to readers 1 and 2. Only reader six had a tendency to give few points while scoring. In conclusion, training can improve the reliability of the index, and we recommend practicing on a sufficient number of patients and controls prior to clinical application. To our knowledge, this is the first report of a systematic analysis of enthesis interexplorer acquisition with power Doppler (inter-observer reliability of examination), and it shows a very good reliability, with an intra-class correlation coefficient of 0.86 (95% IC: 0.70-0.94). A previous study without Doppler (10) , showed an intra-class correlation coefficient of 0.72 (95% IC: 0.56-0.83). The MASEI score required less than 20 minutes to perform. Therefore, it could be considered feasible and efficient when compared with other diagnostic procedures. Finally, the value of the index is not the fact that in diagnosing a patient, it satisfies traditional SpA classification criteria with a sensitivity of 84% and a specificity of 83%. Rather, the greatest clinical interest is to develop an ultrasound score that can be used in early SpA, which is difficult to diagnose. Prior to accomplishing this, the ability of the score to classify patients and controls with correct diagnoses must be studied. In that respect, the preliminary data applying the MASEI in patients with early SpA show that the proposed score index has a similar utility in the pre-radiographic stage of this disease to that in established disease (20) . The clinical New York criteria have shown a good specificity but a low sensitivity, which contributes to the delay in diagnosis of months or years (3). The sensitivity and specificity of 84% and 82.76%, respectively, reached a satisfactory level that makes it possible to include the MASEI score in a core set of diagnostic criteria for SpA. On the other hand, the 4.83 LR+ can be used in an algorithm based on Bayes' theorem to allow for the calculation of the probability of disease in any individual patient with probable SpA (17). As an example, a pre-test probability of 5% is increased by a positive MASEI only by 20% and decreased to 1% if MASEI is negative. However, used in the clinical setting, with more signs or symptoms it can be decisive.
In summary, this US enthesis study demonstrated that the proposed ultrasound enthesis score is reliable. In addition, it was determined that enthesis ultrasound can be a valid diagnostic tool for SpA in both men and women. Although more data are needed, these results are promising and encourage further research.
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